Friday, July 19, 2024
Mitochondrial Health Presents: CohBar – Breakthrough Mitochondrial Science

CohBar (NASDAQ: CWBR) is a clinical stage biotechnology company focused on the research and development of mitochondria based therapeutics, an emerging class of drugs for the treatment of chronic and age-related diseases.


BioPub is an online subscription service reviewing small-cap biotech companies. It is led by an NIH-trained MD, PhD former medical professor and researcher, and his colleagues. The BioPub team works to identify exceptional companies, representing what it regards as the top decile of biotech investing opportunities on the basis of three concurrent attributes: genuine top-shelf science; credible, competent, and accessible management; and the likelihood that a company’s efforts will permanently alter the landscape of clinical medicine. For more information, visit the company’s website at


Similar Posts